Sugi Predict

Sugi Predict / Compounds / SCHEMBL7406459

SCHEMBL7406459

SCHEMBL7406459

COc1ccccc1OCC(C)=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.72
▸ POLB P06746 2/20 0.72
▸ HSD17B10 Q99714 2/20 0.64
▸ LMNA P02545 2/20 0.58
▸ MTNR1A P48039 1/20 0.57
▸ MTNR1B P49286 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ KMT2A Q03164 3/20 0.55
▸ MAPT P10636 2/20 0.55
▸ HPGD P15428 2/20 0.55
▸ NPC1 O15118 1/20 0.54
▸ TP53 P04637 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.53
▸ MEN1 O00255 2/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ STAT3 P40763 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ CA12 O43570 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2955119 0.92 KMT2A (0.62) SMN1; SMN2POLBHSD17B10LMNAMTNR1A
SCHEMBL10509566 0.86 SMN1; SMN2 (0.75) SMN1; SMN2POLBHSD17B10LMNAMTNR1A
SCHEMBL323801 0.84 POLB (1.00) SMN1; SMN2POLBHSD17B10LMNANPSR1
SCHEMBL2559539 0.84 L3MBTL1 (0.72) SMN1; SMN2POLBHSD17B10LMNAKMT2A
SCHEMBL5520675 0.84 SMN1; SMN2 (0.72) SMN1; SMN2POLBHSD17B10LMNAMTNR1A
SCHEMBL15391794 0.82 SMN1; SMN2 (0.70) SMN1; SMN2POLBHSD17B10LMNAMTNR1A
SCHEMBL28414879 0.82 SMN1; SMN2 (0.70) SMN1; SMN2POLBHSD17B10LMNAMTNR1A
Methyl Alcohol SCHEMBL27939411 0.82 POLB (0.96) SMN1; SMN2POLBHSD17B10LMNANPSR1
SCHEMBL9203434 0.82 SMN1; SMN2 (0.70) SMN1; SMN2POLBHSD17B10LMNAMTNR1A
SCHEMBL27044917 0.82 KMT2A (0.62) SMN1; SMN2POLBHSD17B10LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0521650-B1 Working fluid composition for use in refrigeration system KAO CORP (JP) 1997-08-13 — — EP claimed
CN-114761410-B Pyrrolopyrimidinone compounds and application thereof 广州必贝特医药股份有限公司 2023-08-25 — — CN disclosed
WO-2022213932-A1 PYRROLOPYRIMIDINONE COMPOUND AND APPLICATION THEREOF 广州必贝特医药股份有限公司 2022-10-13 — — WO disclosed
CN-114761410-A Pyrrolopyrimidinone compounds and application thereof 广州必贝特医药股份有限公司 2022-07-15 — — CN disclosed
EP-3235799-B1 OXIME COMPOUND AND HERBICIDE NISSAN CHEMICAL CORP (JP) 2022-02-23 — — EP disclosed
US-11000033-B2 Ketone or oxime compound, and herbicide NISSAN CHEMICAL CORPORATION (JP) 2021-05-11 — — US disclosed
US-20190053488-A1 KETONE OR OXIME COMPOUND, AND HERBICIDE NISSAN CHEMICAL CORPORATION (JP) 2019-02-21 — — US disclosed
US-20170347647-A1 KETONE OR OXIME COMPOUND, AND HERBICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-12-07 — — US disclosed
US-20170347647-A1 KETONE OR OXIME COMPOUND, AND HERBICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-12-07 — — US disclosed
US-20170320833-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-11-09 — — US disclosed
US-20090068140-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2009-03-12 — — US disclosed
US-20080050336-A1 Hepatitis C Virus Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2008-02-28 — — US disclosed
CN-1341090-A Process for preparing benzyl ethers RHODIA CHIMIE SA (FR) 2002-03-20 — — CN disclosed
EP-0521650-B1 Working fluid composition for use in refrigeration system KAO CORP (JP) 1997-08-13 — — EP disclosed
US-5401433-A Base oils with ketone groups for use with hydrofluorocarbons, air conditioners KAO CORPORATION (JP) 1995-03-28 — — US disclosed
US-5300245-A Mixed with hydrofluorocarbons KAO CORPORATION (JP) 1994-04-05 — — US disclosed
EP-0521650-A1 Working fluid composition for use in refrigeration system Kao Corporation (JP) 1993-01-07 — — EP disclosed
US-4503067-A HYPOTENSIVE, ANGINA PECTORIS BOEHRINGER MANNHEIM GMBH (DE) 1985-03-05 — — US disclosed
EP-0004920-B1 DERIVATIVES OF CARBAZOLYL-4-OXYPROPANOLAMINE, METHODS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM Roche Diagnostics GmbH (DE) 1981-08-05 — — EP disclosed
EP-0004920-A1 Derivatives of carbazolyl-4-oxypropanolamine, methods for their preparation and medicines containing them Roche Diagnostics GmbH (DE) 1979-10-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11000033-B2 Ketone or oxime compound, and herbicide OR10J3, CYP1B1, CBR3 SMN1; SMN2 2843/4885POLB 1846/4885HSD17B10 117/4885
US-20080050336-A1 Hepatitis C Virus Inhibitors HAVCR2, PYGL, HCCS SMN1; SMN2 4352/4885POLB 1431/4885HSD17B10 1305/4885
US-20090068140-A1 HEPATITIS C VIRUS INHIBITORS HAVCR2, PYGL, HCCS SMN1; SMN2 4352/4885POLB 1431/4885HSD17B10 1305/4885
US-20170320833-A1 HEPATITIS C VIRUS INHIBITORS HAVCR2, PYGL, HCCS SMN1; SMN2 4352/4885POLB 1431/4885HSD17B10 1305/4885
US-20190053488-A1 KETONE OR OXIME COMPOUND, AND HERBICIDE OR10J3, CYP1B1, CBR3 SMN1; SMN2 2838/4885POLB 1859/4885HSD17B10 119/4885
US-20170347647-A1 KETONE OR OXIME COMPOUND, AND HERBICIDE OR10J3, CYP1B1, CBR3 SMN1; SMN2 2838/4885POLB 1859/4885HSD17B10 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.